These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 3047638)
21. Factor B (Bf) and glyoxalase genes in insulin-dependent diabetes mellitus. Allannic H; Fauchet R; Gueguen M; Pheng Savath H; Dinh Knoi T; Genetet B Diabete Metab; 1985 Feb; 11(1):22-6. PubMed ID: 3856541 [TBL] [Abstract][Full Text] [Related]
22. Study of cis and trans interactions between extended HLA-haplotypes in insulin-dependent diabetes. Deschamps I; Marcelli-Barge A; Lallemand N; Poirier JC; Bochu V; Prévost P; Busson A; Massét M; Lestradet H; Hors J Tissue Antigens; 1988 May; 31(5):259-69. PubMed ID: 3400091 [TBL] [Abstract][Full Text] [Related]
23. Genetic heterogeneity of insulin-dependent (type I) diabetes mellitus: evidence from a study of extended haplotypes. Rich SS; Weitkamp LR; Barbosa J Am J Hum Genet; 1984 Sep; 36(5):1015-23. PubMed ID: 6594040 [TBL] [Abstract][Full Text] [Related]
24. Marked shortage of C4B DNA polymorphism among insulin-dependent diabetic patients. Marcelli-Barge A; Poirier JC; Chantome R; Deschamps I; Hors J; Colombani J Res Immunol; 1990 Feb; 141(2):117-28. PubMed ID: 1975115 [TBL] [Abstract][Full Text] [Related]
25. The HLAB*18,BF*F1 in haplotype in type 1 diabetes. Walsh LJ; Cox DW; Ehrlich RM Am J Med Genet; 1982 Mar; 11(3):337-43. PubMed ID: 6952765 [TBL] [Abstract][Full Text] [Related]
26. Gene and haplotype frequencies of the fourth component of complement (C4) in type 1 diabetics and normal controls. Bertrams J; Hintzen U; Schlicht V; Schoeps S; Gries FA; Louton TK; Baur MP Immunobiology; 1984 May; 166(4-5):335-44. PubMed ID: 6480029 [TBL] [Abstract][Full Text] [Related]
27. Extended HLA haplotypes in families with insulin-dependent diabetes mellitus in northern Finland. Ilonen J; Surcel HM; Partanen J; Koskimies S; Knip M; Käär ML Tissue Antigens; 1988 Sep; 32(3):139-44. PubMed ID: 3217930 [TBL] [Abstract][Full Text] [Related]
28. HLA antigens in insulin dependent and non-insulin dependent Spanish diabetic patients. Serrano-Ríos M; Regueiro JR; Severino R; López-Larrea C; Arnaiz-Villena A Diabete Metab; 1983; 9(2):116-20. PubMed ID: 6352349 [TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphism of the fourth component of complement and type 1 (insulin-dependent) diabetes. Marcelli-Barge A; Poirier JC; Schmid M; Deschamps I; Lestradet H; Prevost P; Hors J Diabetologia; 1984 Jul; 27 Suppl():116-7. PubMed ID: 6332752 [TBL] [Abstract][Full Text] [Related]
30. [Study of the HLA system and glyoxalase in 31 insulin-dependent diabetics free from micro and macro-angiopathies after more than a 20-year development]. Pointel JP; Missenard V; Raffoux C; Marcelli-Barge A; Dausset J; Drouin P; Debry G J Mal Vasc; 1989; 14(1):1-9. PubMed ID: 2921565 [TBL] [Abstract][Full Text] [Related]
31. HLA A, B, and DR antigens and complotype in Tunisian patients with diabetes mellitus. Ayed K; Bardi R; Gorgi Y; Jenhani F; Chammakhi S; Boukhris R Dis Markers; 1989; 7(1):43-7. PubMed ID: 2714046 [TBL] [Abstract][Full Text] [Related]
32. Human MHC class III (Bf, C2, C4) genes and GLO: their association with other HLA antigens and extended haplotypes in the Spanish population. Regueiro JR; Arnaiz-Villena A Tissue Antigens; 1988 Jan; 31(1):14-25. PubMed ID: 3341017 [TBL] [Abstract][Full Text] [Related]
33. C4 Chido 3 and 6 distinguish two diabetogenic haplotypes: HLA-B49, SC01,DR4,DQw8 and B8,SC01,DR3,DQw2. Segurado OG; Giles CM; Iglesias-Casarrubios P; Corell A; Martinez-Laso J; Vicario JL; Arnaiz-Villena A Immunobiology; 1991 Sep; 183(1-2):12-22. PubMed ID: 1682241 [TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of the disease-associated complement C4 gene from the HLA-A1, B8, DR3 haplotype. Ulgiati D; Abraham LJ Exp Clin Immunogenet; 1996; 13(1):43-54. PubMed ID: 8854088 [TBL] [Abstract][Full Text] [Related]
35. The HLA system in the Korean population. Kim SJ; Nisperos B; Mickelson E; Choi IH; Dahlberg S; Kim JD; Giblett ER; Hansen JA Hum Immunol; 1986 Nov; 17(3):259-72. PubMed ID: 3793531 [TBL] [Abstract][Full Text] [Related]
36. Extended major histocompatibility complex haplotypes in type I diabetes mellitus. Raum D; Awdeh Z; Yunis EJ; Alper CA; Gabbay KH J Clin Invest; 1984 Aug; 74(2):449-54. PubMed ID: 6746903 [TBL] [Abstract][Full Text] [Related]
37. HLA and GM in insulin-dependent diabetes in the Netherlands: report on a combined multiplex family and population study. de Jongh BM; Bruining GJ; Schreuder GM; Schuurman RK; Radder JK; van Loghem E; Meera Khan P; Hauptmann G; van Rood JJ Hum Immunol; 1984 May; 10(1):5-21. PubMed ID: 6586708 [TBL] [Abstract][Full Text] [Related]
38. MHC supratypes as markers of null and defective C4 alleles in a Thai/Chinese population: relevance to disease susceptibility. Kay PH; Grimsley G; Dawkins RL; Charoenwong P Dis Markers; 1987 Mar; 5(1):43-7. PubMed ID: 3502980 [TBL] [Abstract][Full Text] [Related]
39. Lack of preferential transmission of diabetic HLA alleles by healthy parents to offspring in Spanish diabetic families. Martin-Villa JM; Vicario JL; Martinez-Laso J; Serrano-Rios M; Lledó G; Damiano A; Hawkins F; Regueiro JR; Arnaiz-Villena A J Clin Endocrinol Metab; 1990 Feb; 70(2):346-8. PubMed ID: 2298852 [TBL] [Abstract][Full Text] [Related]
40. The genetics of Type 1 (insulin-dependent) diabetes. Cudworth AG; Wolf E Curr Probl Clin Biochem; 1983; 12():45-64. PubMed ID: 6418443 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]